Related Experiment Video

Updated: Apr 18, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.9K

Beclin 1 regulates growth factor receptor signaling in breast cancer

R A Rohatgi1, J Janusis1, D Leonard2

  • 1Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA, USA.

Oncogene
|February 3, 2015
PubMed

Insights

Beclin 1, a tumor suppressor, regulates growth factor signaling in breast cancer by controlling endosome maturation. Loss of beclin 1 enhances tumor cell invasion by sustaining AKT and ERK activation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Beclin 1 is a tumor suppressor often decreased in human cancers, primarily linked to its role in macroautophagy.
  • Beclin 1 is a key component of the Vps34/PI3KC3 complex, regulating membrane trafficking.
  • Its precise functions beyond autophagy in cancer progression remain under investigation.

Purpose of the Study:

  • To investigate an alternative mechanism of beclin 1 action in breast cancer.
  • To elucidate beclin 1's role in regulating growth factor receptor signaling and endosome maturation.
  • To determine the impact of beclin 1 suppression on breast carcinoma cell invasion.

Main Methods:

  • Studied the transition of early endosomes from PI3P(-) to PI3P(+) states.
  • Assessed beclin 1's regulation of phosphoinositide production in response to growth factors.
  • Analyzed the effect of BECN1 suppression on AKT and ERK activation and breast carcinoma cell invasion.
  • Correlated beclin 1 expression with AKT and ERK phosphorylation in human breast tumors.

Main Results:

  • Beclin 1 regulates early endosome maturation, specifically the transition to PI3P(+) endosomes.
  • Beclin 1 controls the duration of growth factor receptor signaling by modulating PI3P production.
  • Suppression of BECN1 leads to sustained AKT and ERK activation, promoting breast carcinoma cell invasion.
  • A negative correlation exists between beclin 1 expression and AKT/ERK phosphorylation in human breast tumors.

Conclusions:

  • Beclin 1 plays a novel role in regulating growth factor signaling pathways in breast cancer.
  • Loss of beclin 1 function enhances breast cancer progression through sustained pro-invasive signaling.
  • Targeting beclin 1-mediated signaling represents a potential therapeutic strategy for breast cancer.

More Related Videos

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.6K
An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

8.7K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K